Steven Valiquette
Stock Analyst at Mizuho
(3.50)
# 892
Out of 4,944 analysts
112
Total ratings
57.14%
Success rate
3.01%
Average return
Main Sectors:
Stocks Rated by Steven Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVST Envista Holdings | Maintains: Underperform | $15 → $18 | $21.56 | -16.51% | 2 | Aug 1, 2025 | |
| TDOC Teladoc Health | Initiates: Neutral | $10 | $7.44 | +34.41% | 1 | Jul 25, 2025 | |
| WAY Waystar Holding | Initiates: Outperform | $48 | $35.35 | +35.79% | 1 | Jun 30, 2025 | |
| VEEV Veeva Systems | Maintains: Outperform | $280 → $295 | $279.18 | +5.67% | 3 | Jun 2, 2025 | |
| DOCS Doximity | Maintains: Neutral | $65 → $60 | $64.02 | -6.28% | 3 | May 16, 2025 | |
| ALGN Align Technology | Maintains: Outperform | $250 → $245 | $145.74 | +68.11% | 11 | Apr 29, 2025 | |
| MCK McKesson | Maintains: Neutral | $630 → $690 | $663.17 | +4.05% | 3 | Apr 3, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $142 → $150 | $148.12 | +1.27% | 6 | Mar 31, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $21 → $18 | $13.85 | +29.96% | 7 | Mar 13, 2025 | |
| SOLV Solventum | Maintains: Neutral | $70 → $82 | $74.38 | +10.24% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $7 | $6.89 | +1.60% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $126 | $89.27 | +41.14% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $75 | $68.99 | +8.71% | 5 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $2.58 | +93.80% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $14 | $5.33 | +162.66% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $142 | $178.51 | -20.45% | 10 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 | $68.01 | -19.13% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $82 → $92 | $163.04 | -43.57% | 10 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $565 | $271.81 | +107.87% | 5 | Apr 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $65.90 | +51.75% | 1 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $14 | $4.13 | +238.98% | 1 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $380 → $400 | $161.21 | +148.12% | 4 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $107 | $27.07 | +295.27% | 1 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $22 → $17 | $33.08 | -48.61% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $5 → $12 | $7.39 | +62.38% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $96 | $119.13 | -19.42% | 3 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $105 → $120 | $179.04 | -32.98% | 6 | Apr 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $127 | $390.46 | -67.47% | 1 | Apr 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $327 → $358 | $281.99 | +26.95% | 3 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $78 → $60 | $11.89 | +404.63% | 3 | Apr 3, 2019 |
Envista Holdings
Aug 1, 2025
Maintains: Underperform
Price Target: $15 → $18
Current: $21.56
Upside: -16.51%
Teladoc Health
Jul 25, 2025
Initiates: Neutral
Price Target: $10
Current: $7.44
Upside: +34.41%
Waystar Holding
Jun 30, 2025
Initiates: Outperform
Price Target: $48
Current: $35.35
Upside: +35.79%
Veeva Systems
Jun 2, 2025
Maintains: Outperform
Price Target: $280 → $295
Current: $279.18
Upside: +5.67%
Doximity
May 16, 2025
Maintains: Neutral
Price Target: $65 → $60
Current: $64.02
Upside: -6.28%
Align Technology
Apr 29, 2025
Maintains: Outperform
Price Target: $250 → $245
Current: $145.74
Upside: +68.11%
McKesson
Apr 3, 2025
Maintains: Neutral
Price Target: $630 → $690
Current: $663.17
Upside: +4.05%
Cardinal Health
Mar 31, 2025
Maintains: Outperform
Price Target: $142 → $150
Current: $148.12
Upside: +1.27%
DENTSPLY SIRONA
Mar 13, 2025
Maintains: Neutral
Price Target: $21 → $18
Current: $13.85
Upside: +29.96%
Solventum
Mar 3, 2025
Maintains: Neutral
Price Target: $70 → $82
Current: $74.38
Upside: +10.24%
Dec 4, 2024
Initiates: Neutral
Price Target: $7
Current: $6.89
Upside: +1.60%
Dec 4, 2024
Initiates: Outperform
Price Target: $126
Current: $89.27
Upside: +41.14%
Dec 4, 2024
Initiates: Neutral
Price Target: $75
Current: $68.99
Upside: +8.71%
Dec 4, 2024
Initiates: Outperform
Price Target: $5
Current: $2.58
Upside: +93.80%
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $18 → $14
Current: $5.33
Upside: +162.66%
Sep 21, 2023
Maintains: Equal-Weight
Price Target: $142
Current: $178.51
Upside: -20.45%
Aug 4, 2023
Maintains: Overweight
Price Target: $55
Current: $68.01
Upside: -19.13%
Aug 2, 2023
Maintains: Overweight
Price Target: $82 → $92
Current: $163.04
Upside: -43.57%
Apr 14, 2023
Maintains: Overweight
Price Target: $565
Current: $271.81
Upside: +107.87%
Mar 30, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $65.90
Upside: +51.75%
Feb 27, 2023
Maintains: Overweight
Price Target: $17 → $14
Current: $4.13
Upside: +238.98%
Oct 28, 2022
Maintains: Overweight
Price Target: $380 → $400
Current: $161.21
Upside: +148.12%
Jul 28, 2022
Reinstates: Overweight
Price Target: $107
Current: $27.07
Upside: +295.27%
Apr 18, 2022
Downgrades: Equal-Weight
Price Target: $22 → $17
Current: $33.08
Upside: -48.61%
Jun 11, 2021
Upgrades: Overweight
Price Target: $5 → $12
Current: $7.39
Upside: +62.38%
Nov 23, 2020
Upgrades: Overweight
Price Target: $96
Current: $119.13
Upside: -19.42%
Apr 30, 2020
Reiterates: Neutral
Price Target: $105 → $120
Current: $179.04
Upside: -32.98%
Apr 22, 2020
Maintains: Overweight
Price Target: $117 → $127
Current: $390.46
Upside: -67.47%
Dec 6, 2019
Maintains: Overweight
Price Target: $327 → $358
Current: $281.99
Upside: +26.95%
Apr 3, 2019
Maintains: Equal-Weight
Price Target: $78 → $60
Current: $11.89
Upside: +404.63%